DiaSorin (OTCMKTS:DSRLF) Downgraded by UBS Group to “Hold”

UBS Group cut shares of DiaSorin (OTCMKTS:DSRLF) from a strong-buy rating to a hold rating in a research note issued to investors on Tuesday morning,Zacks.com reports.

DiaSorin Price Performance

DSRLF opened at $107.88 on Tuesday. DiaSorin has a 1 year low of $107.88 and a 1 year high of $107.88. The stock has a 50-day moving average price of $103.07 and a 200-day moving average price of $103.07.

DiaSorin Company Profile

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.